Prevalence and follow-up of potentially inappropriate medication and potentially omitted medication in older patients with cancer – The PIM POM study

ObjectivesTo determine the prevalence of Potentially Inappropriate Medication (PIMs) and Omitted (POMs) in older patients with cancer.Materials MethodsIn this prospective observational study (hospital) pharmacists conducted comprehensive medication reviews cancer (aged ≥65 years) receiving parenteral chemotherapy and/or immunotherapy at Deventer Hospital. PIMs POMs were identified using Screening Tool Older Persons' potentially inappropriate Prescriptions (STOPP), to Alert doctors Right Treatment (START), pharmacists' expert opinion. Recommendations regarding communicated patient's oncologist/haematologist follow-up was measured. Associations between covariates statistically analysed.ResultsFor 150 included, 180 86 a 78%. Using opinion addition only STOPP/START criteria contributed 49% 23% POMs. A action required 73% 266 Number medicines Charlson Comorbidity Index score both associated having least one PIM POM (p = .031 p .016, respectively).ConclusionThe subsequent is high. pharmacist-led review good instrument identify these optimize patients' treatment. complete approach, including opinion, recommended all clinical practice.